Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 695-716-9 | CAS number: 1174931-74-8
Endpoint summary
Administrative data
Description of key information
Eye irritation/corrosion: Irritant, EpiOcular Human Tissue model; pre-validated ocular Irritation Assay for Irritant/Non-Irritant classification using the EpiOcular Human Tissue Model guideline, Lehmeier 2012
Skin irritation/corrosion: Non-irritant, OECD 439 guideline, Commission Regulation (EC) No. 761/2009, Lehmeier 2012
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: According to internationally recognised guideline; under GLP conditions.
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline for the Testing of Chemicals No. 439: In Vitro Skin Irritation: Reconstructed human Epidermis Test Method, 22 July 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Commission Regulation (EC) No. 761/2009, L 220, Annex III Part B.46. “ In vitro Skin Irritation: Reconstructed Human Epidermis Model Test”. 23-Jul-2009
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: L’Oréal Standard Operating Procedure: “EpiSkin Skin Irritation Test Method“; -ECVAM Skin Irritation Validation Study - Validation of the EpiSkin Test Method for the Prediction of Acute Skin 15 min - 42 hours Irritation of Chemicals. Version 1.8, Feb-2009
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ECVAM Performance Standards for in vitro Skin Irritation Test Methods based on Reconstructed human Epidermis (RhE). Updated Version 24-Aug-2009
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ISO/FDIS 10993-10, Annex D: 2009(E), “Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization”
- Deviations:
- no
- GLP compliance:
- yes
- Species:
- other: in vitro: EPISKIN Standard model
- Strain:
- other: n/a
- Details on test animals or test system and environmental conditions:
- The test was performed with the reconstituted 3-dimensional human skin model, EPISKIN-SM. The skin model consists of normal adult human-derived epidermal keratinocytes (NHEK) which have been cultured to form a multilayered, highly differentiated model of the human epidermis. The NHEK are cultured on modified collagen-coated cell culture inserts. A highly differentiated and stratified epidermis model is obtained after a 13-day culture period comprising of the main basal, supra basal, spinous and granualr layers and a functional stratum corneum.
- Type of coverage:
- open
- Preparation of test site:
- other: no preparation of the test site
- Vehicle:
- water
- Controls:
- other: additional tissues in triplicate were available for the positive and negative control groups.
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 10 mg (with 5ul distilled water)
VEHICLE
- name: distilled water
- Amount(s) applied for moistening (volume or weight with unit): 5 ul
NEGATIVE CONTROL
- name: Phosphate buffered saline (PBS)
- Amount(s) applied (volume or weight with unit): 10 ul
POSITIVE CONTROL
- name: sodium dodecyl sulfate (SDS)
- Amount(s) applied (volume or weight with unit): 10 ul of 5% SDS solution - Duration of treatment / exposure:
- 15 minutes
- Details on study design:
- Pre-test: to check the MTT reducing ability of the test material, 10mg of the test material was mixed with 2 ml of MTT medium and incubated for 3 hours at 37 degrees C in the dark.
Main test: The test was performed with triplicate tissues for the test substance, positive and control groups. The test material was applied to directly on top of the skin tissue. After the exposure period of 15 minutes at room temperature, the tissues were washed with PBS to remove residual test substance. The skin tissues were transferred to new well plates containing maintainance medium incubated at 37 +/-1 degrees C, 5% CO2 for 42 hours. After the 42 hour incubation period, determination of cytotoxic effect was performed. Tissues were transferred into an MTT assay plate (containing prewarmed MTT solution) and incubated for 3 hours at 37 +/- 1 degrees C, 5% CO2. After incubation, a biopsy of each tissue were transferred to tube containing isopropanol and kept over the weekend in the dark at 2-8 degrees C. The OD of the extracts were measured using a spectrophotometer. - Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study, the test material showed no irritant effects producing a mean relative tissue viability of 83.7%. Therefore the test material is considered to be a non-irritant. The positive and negative control groups achieved the expected result and confirm the validity of this study.
- Executive summary:
This study protocol is based on OECD 439 guideline; Commission Regulation (EC) No. 761/2009, L 220, Annex III Part B.46; L’Oréal Standard Operating Procedure: “EpiSkin Skin Irritation Test Method“; -ECVAM Skin Irritation Validation Study - Validation of the EpiSkin Test Method for the Prediction of Acute Skin 15 min - 42 hours Irritation of Chemicals. Version 1.8; ECVAM Performance Standards for in vitro Skin Irritation Test Methods based on Reconstructed human Epidermis (RhE); ISO/FDIS 10993-10, Annex D: 2009(E); and was performed under GLP conditions. EPISKIN tissue were exposed to 10 mg of test material (applied directly to the tissue with 5ul distilled water) for 15 minutes. After exposure tissues were rinsed and further incubated for a 42 hours at 37 degrees C. After this incubation period, determination of the cytotoxic effect was performed by transferring tissues to plates containing MTT medium and incubated for 3 hours. Tissue biopsies were taken and extraction of contents were performed by placing tissues in isopropanol. The OD of the extracts were measured using a spectrophotometer to determine cytotoxicity. Under the conditions of this study, the test material showed no irritant effects producing a mean relative tissue viability of 83.7%. The test material is considered to be a non-irritant. The positive and negative control groups achieved the expected result and confirm the validity of this study.
Reference
Pre-test: The test material did not cause the MTT to change colour to blue/purple indicating that the test material does not have MTT-reducing capability.
Results of the main test are shown in the following table:
| Name | Negative Control | Positive Control | Test Material | ||||||
| 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | |
| Absolute OD 550nm | 1.325 | 1.338 | 1.225 | 0.144 | 0.135 | 0.138 | 1.016 | 1.148 | 1.114 |
| 1.26 | 1.311 | 1.196 | 0.143 | 0.131 | 0.144 | 0.966 | 1.133 | 1.075 | |
| Blank corrected OD 550nm | 1.282 | 1.295 | 1.182 | 0.102 | 0.092 | 0.095 | 0.973 | 1.105 | 1.071 |
| 1.217 | 1.268 | 1.153 | 0.1 | 0.089 | 0.101 | 0.923 | 1.09 | 1.032 | |
| Mean OD 550nm (blank corrected) | 1.25 | 1.282 | 1.168 | 0.101 | 0.09 | 0.098 | 0.948 | 1.098 | 1.052 |
| Total mean OD 550nm of 3 replicate tissues (blank-corrected) | 1.233 | 0.096 | 1.033 | ||||||
| SD OD 550nm | 0.06 | 0.01 | 0.07 | ||||||
| Relative tissue viabilities (%) | 101.4 | 103.9 | 94.7 | 8.2 | 7.3 | 8 | 76.9 | 89 | 85.3 |
| Mean tissue viabilities (%) | 100 | 7.8 | 83.7 | ||||||
| SD tissue viability (%) | 4.8 | 0.4 | 6.2 | ||||||
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: According to internationally recognised guideline; under GLP conditions.
- Qualifier:
- according to guideline
- Guideline:
- other: Occular irritation assay for irritant/non-irritant classification using the EpiOcular human tissue model
- Deviations:
- no
- Principles of method if other than guideline:
- This method has been designed to predict and classify the occular irritation potential of a chemical by assessment on its effect on EpiOcular, a non-ocular human epithelial cell model. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT after test material exposure. The EpiOcular Eye Irritation Test (EIT) protocol has been pre-validated by COLIPA and is currently under validation by ECVAM (validation still ongoing).
- GLP compliance:
- yes
- Species:
- other: in vitro: EpiOcular human tissue model
- Strain:
- other: n/a
- Details on test animals or tissues and environmental conditions:
- The test was performed with the EpiOcular corneal model (MatTek). The model consists of normal, human-derived epidermal keratinocytes that have been cultured to form a stratified, squamous epithelium similar to that found in the cornea. The epidermal cells, which are cultured on specially prepared cell culture inserts using serum free medium differentiate to form a multi-layered structure which closely parallels the corneal epithelium.
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: additional tissue was available for negative and positive control groups.
- Amount / concentration applied:
- Test material:
50 mg of test material was applied directly to the surface of the EpiOcular tissue. - Duration of treatment / exposure:
- 90 minutes
- Details on study design:
- Pre-test: to check the MTT reducing ability of the test material, 50mg of the test material was mixed with 500 ul of MTT medium and incubated for 2 hours at room temperature.
Main test: The test was performed on each dose group in duplicate, together with negative and positive controls. After dosing, the tissues were incubated for 90 +/- 5 minutes at 37 +/- 1 degrees C, 5% CO2 / 95% air. After the exposure period, tissues were rinsed with DPBS to remove test material. Tissues were then transferred to an post-soak plate (with prewarmed assay medium) and incubated for 12 minutes at room temperature. These tissues were further transferred to a post treatment plate (containing prewarmed assay medium) and incubated for 18 +/- 0.25 h at 37 +/- 1 degrees C, 5% CO2 / 95% air. After this incubation period, determination of the cytotoxic effect was performed. Tissues were transferred into an MTT assay plate (containing prewarmed MTT solution) and incubated for 180 +/- 10 minutes at 37 +/- 1 degrees C, 5% CO2 / 95% air. After incubation, tissues were transferred to 'extraction plates' containing 2ml of isopropanol and kept overnight (in sealed bags to reduce evaporation of isopropanol) in the dark at 2-8 degrees C. Tissue were then discarded and the OD of the extracts were measured using a spectrophotometer. - Interpretation of results:
- irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- Under the conditions of this study, the test material showed irritant effects producing a mean relative viability of 1.70%. Therefore the test material is considered to be an irritant. The positive and negative control groups achieved the expected result and confirm the validity of this study.
- Executive summary:
This study protocol is based on pre-validated ocular Irritation Assay for Irritant/Non-Irritant classification using the EpiOcular Human Tissue Model guideline. EpiOcular tissue were exposed to 50 mg of test material (applied directly to the tissue without vehicle) for 90 minutes. After exposure tissues were rinsed and further incubated for an additional 12 minutes at room temperature then 180 minutes at 37 degrees C. After this incubation period, determination of the cytotoxic effect was performed by transferring tissues to plates containing MTT medium and incubated for 2 hours. Extraction of tissue contents were performed by placing tissues in isopropanol overnight. Tissues were discarded and the OD of the extracts were measured using a spectrophotometer to determine cytotoxicity. Under the conditions of this study, the test material showed irritant effects producing a mean relative tissue viability of 1.70%. The test material is considered to be an irritant. The positive and negative control groups achieved the expected result and confirm the validity of this study.
Reference
Pre-test: The test material did not cause the MTT to change colour to blue/purple indicating that the test material does not have MTT-reducing capability.
Results of the main test are shown in the table below:
| Name | Negative Control | Positive Control | Test Material | |||
| Replicate 1 | Replicate 2 | Replicate 1 | Replicate 2 | Replicate 1 | Replicate 2 | |
| Mean OD 550nm (blank corrected) | 1.00 | 1.17 | 0.02 | 0.01 | 0.02 | 0.02 |
| Total mean OD 550nm of 2 replicate tissues (blank corrected) | 1.09 | 0.01 | 0.02 | |||
| SD OD 550nm | 0.10 | 0.00 | 0.00 | |||
| Relative tissue viability (%) | 91.90 | 108.10 | 1.40 | 1.20 | 1.80 | 1.70 |
| SD tissue viability (%) | 11.50 | 0.10 | 0.10 | |||
| Mean tissue viability (%) | 100.00 | 1.30 | 1.70 | |||
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Eye irritation:
This study protocol is based on pre-validated ocular Irritation Assay for Irritant/Non-Irritant classification using the EpiOcular Human Tissue Model guideline. EpiOcular tissue were exposed to 50 mg of test material (applied directly to the tissue without vehicle) for 90 minutes. After exposure tissues were rinsed and further incubated for an additional 12 minutes at room temperature then 180 minutes at 37 degrees C. After this incubation period, determination of the cytotoxic effect was performed by transferring tissues to plates containing MTT medium and incubated for 2 hours. Extraction of tissue contents were performed by placing tissues in isopropanol overnight. Tissues were discarded and the OD of the extracts were measured using a spectrophotometer to determine cytotoxicity. Under the conditions of this study, the test material showed irritant effects producing a mean relative tissue viability of 1.70%. The test material is considered to be an irritant. The positive and negative control groups achieved the expected result and confirm the validity of this study.
Skin irritation/corrosion:
This study protocol is based on OECD 439 guideline; Commission Regulation (EC) No. 761/2009, L 220, Annex III Part B.46; L’Oréal Standard Operating Procedure: “EpiSkin Skin Irritation Test Method“; -ECVAM Skin Irritation Validation Study - Validation of the EpiSkin Test Method for the Prediction of Acute Skin 15 min - 42 hours Irritation of Chemicals. Version 1.8; ECVAM Performance Standards for in vitro Skin Irritation Test Methods based on Reconstructed human Epidermis (RhE); ISO/FDIS 10993-10, Annex D: 2009(E); and was performed under GLP conditions. EPISKIN tissue were exposed to 10 mg of test material (applied directly to the tissue with 5ul distilled water) for 15 minutes. After exposure tissues were rinsed and further incubated for a 42 hours at 37 degrees C. After this incubation period, determination of the cytotoxic effect was performed by transferring tissues to plates containing MTT medium and incubated for 3 hours. Tissue biopsies were taken and extraction of contents were performed by placing tissues in isopropanol. The OD of the extracts were measured using a spectrophotometer to determine cytotoxicity. Under the conditions of this study, the test material showed no irritant effects producing a mean relative tissue viability of 83.7%. The test material is considered to be a non-irritant. The positive and negative control groups achieved the expected result and confirm the validity of this study.
Justification for selection of skin irritation / corrosion endpoint:
One study available; GLP compliant and has a Klimisch score 1.
Justification for selection of eye irritation endpoint:
One study available; GLP compliant and has a Klimisch score 1.
Effects on eye irritation: irritating
Justification for classification or non-classification
The test substance does not meet classification criteria under EU Directive 67/548/EEC for dermal irritation.
The test substance does not meet classification criteria under Regulation (EC) No 1272/2008 for dermal irritation.
The substance meets the classification criteria under EU Directive 67/548/EEC as irritating to the eyes; R36.
The substance meets the classification criteria under Regulation (EC) No 1272/2008 for eye irritation category 2
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
